StockWaves
  • Home
  • Global Markets
    Global MarketsShow More
    Up 30% this 12 months, the BP share value nonetheless seems to be undervalued regardless of oil surging. What’s the catch?
    Up 30% this 12 months, the BP share value nonetheless seems to be undervalued regardless of oil surging. What’s the catch?
    4 Min Read
    Bankers readying Paramount’s B debt sale for Warner Bros. – Bloomberg (PSKY:NASDAQ)
    Bankers readying Paramount’s $49B debt sale for Warner Bros. – Bloomberg (PSKY:NASDAQ)
    0 Min Read
    Trump flexes endorsement energy for Ken Paxton after ousting Cassidy
    Trump flexes endorsement energy for Ken Paxton after ousting Cassidy
    10 Min Read
    Type 13G Practical Manufacturers Inc. For: 19 Might
    Type 13G Practical Manufacturers Inc. For: 19 Might
    0 Min Read
    CleanSpark Jumps 6.1% After Macquarie Maintains Outperform
    CleanSpark Jumps 6.1% After Macquarie Maintains Outperform
    3 Min Read
  • Investment Strategies
    Investment StrategiesShow More
    NATO assembly Sweden: Rubio to debate Europe troop ranges, defence spending, Arctic safety
    NATO assembly Sweden: Rubio to debate Europe troop ranges, defence spending, Arctic safety
    5 Min Read
    Trump Delays Iran Strike Determination After Qatar and UAE Calls on Peace Talks
    Trump Delays Iran Strike Determination After Qatar and UAE Calls on Peace Talks
    4 Min Read
    Ought to buyers fear when even optimists flip cautious?
    Ought to buyers fear when even optimists flip cautious?
    10 Min Read
    Why Gold-Backed Stablecoins Are Immediately Changing into A Massive Subject In India’s Crypto Business?
    Why Gold-Backed Stablecoins Are Immediately Changing into A Massive Subject In India’s Crypto Business?
    6 Min Read
    Face Worth change in a fund of Shriram Mutual Fund
    Face Worth change in a fund of Shriram Mutual Fund
    0 Min Read
  • Market Analysis
    Market AnalysisShow More
    CII Jharkhand meets Hemant Soren on industrial coverage and EV ecosystem growth
    CII Jharkhand meets Hemant Soren on industrial coverage and EV ecosystem growth
    3 Min Read
    The way to make investments on your daughter’s training and wedding ceremony targets
    The way to make investments on your daughter’s training and wedding ceremony targets
    8 Min Read
    Multibagger defence inventory jumps over 15% after This autumn outcomes. Alternative maintains bullish outlook with ₹365 goal
    Multibagger defence inventory jumps over 15% after This autumn outcomes. Alternative maintains bullish outlook with ₹365 goal
    5 Min Read
    How Investing.com’s AI Technique Predicted the Rally in Vedanta, Nuvama & SAIL on Might 1st
    How Investing.com’s AI Technique Predicted the Rally in Vedanta, Nuvama & SAIL on Might 1st
    6 Min Read
    Indian rupee falls in opposition to US greenback in 2026 as oil costs and outflows rise
    Indian rupee falls in opposition to US greenback in 2026 as oil costs and outflows rise
    7 Min Read
  • Trading
    TradingShow More
    Brief-Vendor Assaults Everspin Inventory — This is What You Want To Know – Everspin Applied sciences (NASDAQ:MRAM)
    Brief-Vendor Assaults Everspin Inventory — This is What You Want To Know – Everspin Applied sciences (NASDAQ:MRAM)
    3 Min Read
    Carl Icahn Beat Berkshire Final Quarter — However There’s A Catch
    Carl Icahn Beat Berkshire Final Quarter — However There’s A Catch
    2 Min Read
    Why Each EA Vendor Wants an MT5 EA License Key Generator 
    Why Each EA Vendor Wants an MT5 EA License Key Generator 
    12 Min Read
    0 Invested In Hilton Worldwide Holdings 5 Years In the past Would Be Value This A lot At this time – Hilton Worldwide
    $100 Invested In Hilton Worldwide Holdings 5 Years In the past Would Be Value This A lot At this time – Hilton Worldwide
    1 Min Read
    ECARX Holdings Q1 2026 Earnings Name Transcript – ECARX Holdings (NASDAQ:ECX)
    ECARX Holdings Q1 2026 Earnings Name Transcript – ECARX Holdings (NASDAQ:ECX)
    37 Min Read
Reading: An Interview with Dr. Divneet Kaur, CEO of Dermabay
Share
Font ResizerAa
StockWavesStockWaves
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Search
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Follow US
2024 © StockWaves.in. All Rights Reserved.
StockWaves > Business > An Interview with Dr. Divneet Kaur, CEO of Dermabay
Business

An Interview with Dr. Divneet Kaur, CEO of Dermabay

StockWaves By StockWaves Last updated: July 16, 2025 7 Min Read
An Interview with Dr. Divneet Kaur, CEO of Dermabay
SHARE


Contents
An Interview with Dr. Divneet Kaur, a Pharmaceutical Scientist, Co-Founder & CEO of Dermabay, a science-first, formulation-led Indian skincare modelAre you able to share your journey into the pharmaceutical business and what impressed you to co-found Dermabay?What distinctive challenges did you face whereas establishing Dermabay, and the way did you overcome them?Are you able to focus on the analysis and improvement course of behind Dermabay’s merchandise?How does Dermabay differentiate itself from different firms within the pharmaceutical and skincare sectors?How do you guarantee the protection and efficacy of your merchandise throughout the improvement course of?How do you method collaboration with different scientists and researchers within the area?What recommendation would you give to aspiring entrepreneurs within the pharmaceutical business?

An Interview with Dr. Divneet Kaur, a Pharmaceutical Scientist, Co-Founder & CEO of Dermabay, a science-first, formulation-led Indian skincare model

In an unique interview, we converse with Dr. Divneet Kaur, Co-Founder & CEO of Dermabay, a science-first, formulation-led Indian skincare model. Discover her journey and imaginative and prescient for revolutionary magnificence.

Are you able to share your journey into the pharmaceutical business and what impressed you to co-found Dermabay?

Dr. Divneet Kaur: I entered pharmaceutical sciences to specialise in drug supply programs and transdermal peptide applied sciences. The most important subject I noticed throughout my time working throughout analysis labs and mentoring college students was the growing disconnect between scientific breakthroughs and client accessibility of skincare merchandise.

I skilled many requests from folks in my setting about their skincare merchandise failing to ship regardless of their costly pricing and worldwide origins. That was my turning level.

The scientific group in India possessed all mandatory data however did not translate analysis into sensible skincare options. This discovery remodeled into the inspiration that created Dermabay.

What distinctive challenges did you face whereas establishing Dermabay, and the way did you overcome them?

Dr. Divneet Kaur: The most important impediment we confronted was staying away from widespread practices of latest skincare manufacturers which concerned white-labeling or blindly following the traits.

Our firm made an intentional resolution to supply each components internally by conducting thorough testing and taking full accountability for our provide chain administration.

We pursued this method to make sure formulation integrity on the expense of prolonged manufacturing timelines and elevated prices.

The primary problem concerned educating customers in regards to the significance of ingredient transparency and stability alongside bioavailability. We achieved this by telling tales primarily based on scientific details as a substitute of utilizing promotional gimmicks.

Are you able to focus on the analysis and improvement course of behind Dermabay’s merchandise?

Dr. Divneet Kaur: Each product begins with figuring out its scientific goal which incorporates understanding the problem-solution and the actives that present effectiveness below Indian situations.

Our R&D group comprising of pharmaceutical marvels and dermatology consultants begins by growing prototypes which mix steady molecules with optimized absorption patterns and organic compatibility.

Our group then conducts successive rounds of inner product testing which results in modifications primarily based on prompt suggestions. The lengthy deliberate improvement course of allows us to construct skincare merchandise that ship efficiency slightly than traits.

How does Dermabay differentiate itself from different firms within the pharmaceutical and skincare sectors?

Dr. Divneet Kaur: Dermabay connects pharmaceutical-grade formulation to skin-first empathy. Our firm focuses on utilizing imported energetic elements along with advertising tales for skincare merchandise as a result of we think about medical perform alongside indigenous formulation design and long-term pores and skin compatibility.

We don’t promote routines—they’re remodeled into tangible outcomes. Our dedication to scientific excellence and sincere communication about pores and skin well being has remained fixed from our humble beginnings to working with main dermatologists in India.

Our genuine model identification mixed with our full management over formulation mental property makes us distinctive out there.

How do you guarantee the protection and efficacy of your merchandise throughout the improvement course of?

Dr. Divneet Kaur: Our formulations obtain the identical degree of consideration as drug molecules throughout the improvement course of. We prioritize security and efficacy collectively by following these important ideas:

  • Ingredient sourcing from verified suppliers
  • Energetic focus primarily based on medical data
  • Stability testing in assorted Indian temperatures and humidity ranges
  • Patch testing for sensitivity and irritation
  • Compliance with regulatory and dermatological requirements

We check new merchandise on precise customers in managed settings earlier than releasing them into market. All merchandise have to show their efficiency on actual Indian pores and skin by means of knowledge proof and safe confidence earlier than they are often launched to the general public.

How do you method collaboration with different scientists and researchers within the area?

Dr. Divneet Kaur: We contemplate collaboration to be an important obligation as a substitute of an elective selection. Our firm conducts common consultations with dermatologists together with beauty chemists and pharmacologists to enhance our formulation strategies.

Our product prototypes obtain steady suggestions from exterior researchers all through the event course of.

I preserve common contact with educational establishments whereas mentoring younger researchers as a result of I consider scientists ought to work collectively as a substitute of competing towards one another.

What recommendation would you give to aspiring entrepreneurs within the pharmaceutical business?

Dr. Divneet Kaur: Construct for depth, not velocity. Pharmaceutical science requires scientists to show persistence and precision and to keep up a humble method to their work.

Actual-world impact takes priority over fast market entry. Your group ought to embody consultants who each perceive scientific ideas and client wants.

The method of innovation turns into profitable by means of your capability to simplify advanced concepts into easy-to-understand ideas and develop options that deal with real-world issues.

Your credibility capabilities as your monetary useful resource so you could defend it towards any potential threats.

Dr. Kaur’s insights illuminate Dermabay’s dedication to efficient, evidence-based skincare. Her imaginative and prescient empowers customers with scientifically crafted merchandise, shaping the way forward for Indian magnificence.



Are you an
Entrepreneur or Startup?


Do you’ve a Success Story to Share?

SugerMint wish to share your success story.
We cowl entrepreneur Tales, Startup Information, Ladies entrepreneur tales, and Startup tales


Discover Success story of Indian entrepreneurs & startups at SugerMint. Comply with us on Twitter, Instagram, Fb, LinkedIn



Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Previous Article Asian shares decline: Asian shares decline as Fed price lower bets wane Asian shares decline: Asian shares decline as Fed price lower bets wane
Next Article Mike Johnson Breaks Ranks With Trump On The ‘Very Delicate Topic’ Of Epstein: ‘I am For Transparency’ – Tesla (NASDAQ:TSLA) Mike Johnson Breaks Ranks With Trump On The ‘Very Delicate Topic’ Of Epstein: ‘I am For Transparency’ – Tesla (NASDAQ:TSLA)
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow

Subscribe Now

Subscribe to our newsletter to get our newest articles instantly!

Most Popular
Iran alone accounts for almost 80% of worldwide executions in 2025, says report
Iran alone accounts for almost 80% of worldwide executions in 2025, says report
May 20, 2026
Asian shares decline: Asian shares decline as Fed price lower bets wane
Forward of Market: 10 issues that can resolve inventory market motion on Wednesday
May 20, 2026
Up 30% this 12 months, the BP share value nonetheless seems to be undervalued regardless of oil surging. What’s the catch?
Up 30% this 12 months, the BP share value nonetheless seems to be undervalued regardless of oil surging. What’s the catch?
May 20, 2026
CII Jharkhand meets Hemant Soren on industrial coverage and EV ecosystem growth
CII Jharkhand meets Hemant Soren on industrial coverage and EV ecosystem growth
May 20, 2026
FYB Token Formally Launched: Constructing a Subsequent-Technology Platform Token with Deflationary Mechanism and Twin-Cycle Ecosystem
FYB Token Formally Launched: Constructing a Subsequent-Technology Platform Token with Deflationary Mechanism and Twin-Cycle Ecosystem
May 20, 2026

You Might Also Like

‘India’s awe inspiring journey beneath PM Modi’s management…’: Hardeep Singh Puri’s ‘attention-grabbing dialog’ on HARDtalk after 2 a long time
Business

‘India’s awe inspiring journey beneath PM Modi’s management…’: Hardeep Singh Puri’s ‘attention-grabbing dialog’ on HARDtalk after 2 a long time

8 Min Read
In Dialog with Milano7 CEO Pramod Kumar
Business

In Dialog with Milano7 CEO Pramod Kumar

10 Min Read
March Auto Gross sales Preview: Hero MotoCorp, Maruti Suzuki more likely to lead traits; PVs might face headwinds
Business

March Auto Gross sales Preview: Hero MotoCorp, Maruti Suzuki more likely to lead traits; PVs might face headwinds

8 Min Read
Impression Of Local weather Change On Marine Ecosystems || 5 Warning Indicators
Business

Impression Of Local weather Change On Marine Ecosystems || 5 Warning Indicators

6 Min Read

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

StockWaves

We provide tips, tricks, and advice for improving websites and doing better search.

Latest News

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service

Resouce

  • Blockchain
  • Business
  • Economics
  • Financial News
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading

Trending

Iran alone accounts for almost 80% of worldwide executions in 2025, says report
Forward of Market: 10 issues that can resolve inventory market motion on Wednesday
Up 30% this 12 months, the BP share value nonetheless seems to be undervalued regardless of oil surging. What’s the catch?

2024 © StockWaves.in. All Rights Reserved.

Welcome Back!

Sign in to your account

Not a member? Sign Up